4//SEC Filing
Wang Xin Warren 4
Accession 0001225208-19-004354
CIK 0000885725other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:36 PM ET
Size
8.9 KB
Accession
0001225208-19-004354
Insider Transaction Report
Form 4
Wang Xin Warren
SVP and Pres, Asia Pacific
Transactions
- Sale
Common Stock
2019-03-01$40.31/sh−10,000$403,056→ 84,427 total - Exercise/Conversion
Common Stock
2019-02-28+1,629→ 94,427 total - Exercise/Conversion
Deferred Stock Units
2019-02-28−1,629→ 4,888 totalExp: 2022-02-28→ Common Stock (1,629 underlying)
Footnotes (5)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- [F4]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.15 to $40.47, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001725283
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:36 PM ET
- Size
- 8.9 KB